Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease

Yi Zhang, Ashley R. Sandy, Jina Wang, Vedran Radojcic, Gloria T. Shan, Ivy T. Tran, Ann Friedman, Koji Kato, Shan He, Shuaiying Cui, Elizabeth Hexner, Dale M. Frank, Stephen G. Emerson, Warren S. Pear, Ivan Maillard

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Graft-versus-host disease (GVHD) remains the major barrier to the success of allogeneic hematopoietic stem cell transplantation (HSCT). GVHD is caused by donor T cells that mediate host tissue injury through multiple inflammatory mechanisms. Blockade of individual effector molecules has limited efficacy in controlling GVHD. Here, we report that Notch signaling is a potent regulator of T-cell activation, differentiation, and function during acute GVHD. Inhibition of canonical Notch signaling in donor T cells markedly reduced GVHD severity and mortality in mouse models of allogeneic HSCT. Although Notch-deprived T cells proliferated and expanded in response to alloantigens in vivo, their ability to produce interleukin-2 and inflammatory cytokines was defective, and both CD4+ and CD8+ T cells failed to up-regulate selected effector molecules. Notch inhibition decreased the accumulation of alloreactive T cells in the intestine, a key GVHD target organ. However, Notch-deprived alloreactive CD4+ T cells retained significant cytotoxic potential and antileukemic activity, leading to improved overall survival of the recipients. These results identify Notch as a novel essential regulator of pathogenic CD4+ T-cell responses during acute GVHD and suggest that Notch signaling in T cells should be investigated as a therapeutic target after allogeneic HSCT.

Original languageEnglish
Pages (from-to)299-308
Number of pages10
JournalBlood
Volume117
Issue number1
DOIs
Publication statusPublished - Jan 6 2011
Externally publishedYes

Fingerprint

T-cells
Graft vs Host Disease
Grafts
T-Lymphocytes
Hematopoietic Stem Cell Transplantation
Stem cells
Transplantation (surgical)
Molecules
Isoantigens
Multiple Trauma
Intestines
Interleukin-2
Cell Differentiation
Up-Regulation
Chemical activation
Tissue
Cytokines
Mortality

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Zhang, Y., Sandy, A. R., Wang, J., Radojcic, V., Shan, G. T., Tran, I. T., ... Maillard, I. (2011). Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease. Blood, 117(1), 299-308. https://doi.org/10.1182/blood-2010-03-271940

Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease. / Zhang, Yi; Sandy, Ashley R.; Wang, Jina; Radojcic, Vedran; Shan, Gloria T.; Tran, Ivy T.; Friedman, Ann; Kato, Koji; He, Shan; Cui, Shuaiying; Hexner, Elizabeth; Frank, Dale M.; Emerson, Stephen G.; Pear, Warren S.; Maillard, Ivan.

In: Blood, Vol. 117, No. 1, 06.01.2011, p. 299-308.

Research output: Contribution to journalArticle

Zhang, Y, Sandy, AR, Wang, J, Radojcic, V, Shan, GT, Tran, IT, Friedman, A, Kato, K, He, S, Cui, S, Hexner, E, Frank, DM, Emerson, SG, Pear, WS & Maillard, I 2011, 'Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease', Blood, vol. 117, no. 1, pp. 299-308. https://doi.org/10.1182/blood-2010-03-271940
Zhang, Yi ; Sandy, Ashley R. ; Wang, Jina ; Radojcic, Vedran ; Shan, Gloria T. ; Tran, Ivy T. ; Friedman, Ann ; Kato, Koji ; He, Shan ; Cui, Shuaiying ; Hexner, Elizabeth ; Frank, Dale M. ; Emerson, Stephen G. ; Pear, Warren S. ; Maillard, Ivan. / Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease. In: Blood. 2011 ; Vol. 117, No. 1. pp. 299-308.
@article{487df8dc2a7f4c7fb6587179409e6857,
title = "Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease",
abstract = "Graft-versus-host disease (GVHD) remains the major barrier to the success of allogeneic hematopoietic stem cell transplantation (HSCT). GVHD is caused by donor T cells that mediate host tissue injury through multiple inflammatory mechanisms. Blockade of individual effector molecules has limited efficacy in controlling GVHD. Here, we report that Notch signaling is a potent regulator of T-cell activation, differentiation, and function during acute GVHD. Inhibition of canonical Notch signaling in donor T cells markedly reduced GVHD severity and mortality in mouse models of allogeneic HSCT. Although Notch-deprived T cells proliferated and expanded in response to alloantigens in vivo, their ability to produce interleukin-2 and inflammatory cytokines was defective, and both CD4+ and CD8+ T cells failed to up-regulate selected effector molecules. Notch inhibition decreased the accumulation of alloreactive T cells in the intestine, a key GVHD target organ. However, Notch-deprived alloreactive CD4+ T cells retained significant cytotoxic potential and antileukemic activity, leading to improved overall survival of the recipients. These results identify Notch as a novel essential regulator of pathogenic CD4+ T-cell responses during acute GVHD and suggest that Notch signaling in T cells should be investigated as a therapeutic target after allogeneic HSCT.",
author = "Yi Zhang and Sandy, {Ashley R.} and Jina Wang and Vedran Radojcic and Shan, {Gloria T.} and Tran, {Ivy T.} and Ann Friedman and Koji Kato and Shan He and Shuaiying Cui and Elizabeth Hexner and Frank, {Dale M.} and Emerson, {Stephen G.} and Pear, {Warren S.} and Ivan Maillard",
year = "2011",
month = "1",
day = "6",
doi = "10.1182/blood-2010-03-271940",
language = "English",
volume = "117",
pages = "299--308",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease

AU - Zhang, Yi

AU - Sandy, Ashley R.

AU - Wang, Jina

AU - Radojcic, Vedran

AU - Shan, Gloria T.

AU - Tran, Ivy T.

AU - Friedman, Ann

AU - Kato, Koji

AU - He, Shan

AU - Cui, Shuaiying

AU - Hexner, Elizabeth

AU - Frank, Dale M.

AU - Emerson, Stephen G.

AU - Pear, Warren S.

AU - Maillard, Ivan

PY - 2011/1/6

Y1 - 2011/1/6

N2 - Graft-versus-host disease (GVHD) remains the major barrier to the success of allogeneic hematopoietic stem cell transplantation (HSCT). GVHD is caused by donor T cells that mediate host tissue injury through multiple inflammatory mechanisms. Blockade of individual effector molecules has limited efficacy in controlling GVHD. Here, we report that Notch signaling is a potent regulator of T-cell activation, differentiation, and function during acute GVHD. Inhibition of canonical Notch signaling in donor T cells markedly reduced GVHD severity and mortality in mouse models of allogeneic HSCT. Although Notch-deprived T cells proliferated and expanded in response to alloantigens in vivo, their ability to produce interleukin-2 and inflammatory cytokines was defective, and both CD4+ and CD8+ T cells failed to up-regulate selected effector molecules. Notch inhibition decreased the accumulation of alloreactive T cells in the intestine, a key GVHD target organ. However, Notch-deprived alloreactive CD4+ T cells retained significant cytotoxic potential and antileukemic activity, leading to improved overall survival of the recipients. These results identify Notch as a novel essential regulator of pathogenic CD4+ T-cell responses during acute GVHD and suggest that Notch signaling in T cells should be investigated as a therapeutic target after allogeneic HSCT.

AB - Graft-versus-host disease (GVHD) remains the major barrier to the success of allogeneic hematopoietic stem cell transplantation (HSCT). GVHD is caused by donor T cells that mediate host tissue injury through multiple inflammatory mechanisms. Blockade of individual effector molecules has limited efficacy in controlling GVHD. Here, we report that Notch signaling is a potent regulator of T-cell activation, differentiation, and function during acute GVHD. Inhibition of canonical Notch signaling in donor T cells markedly reduced GVHD severity and mortality in mouse models of allogeneic HSCT. Although Notch-deprived T cells proliferated and expanded in response to alloantigens in vivo, their ability to produce interleukin-2 and inflammatory cytokines was defective, and both CD4+ and CD8+ T cells failed to up-regulate selected effector molecules. Notch inhibition decreased the accumulation of alloreactive T cells in the intestine, a key GVHD target organ. However, Notch-deprived alloreactive CD4+ T cells retained significant cytotoxic potential and antileukemic activity, leading to improved overall survival of the recipients. These results identify Notch as a novel essential regulator of pathogenic CD4+ T-cell responses during acute GVHD and suggest that Notch signaling in T cells should be investigated as a therapeutic target after allogeneic HSCT.

UR - http://www.scopus.com/inward/record.url?scp=78650996522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650996522&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-03-271940

DO - 10.1182/blood-2010-03-271940

M3 - Article

C2 - 20870902

AN - SCOPUS:78650996522

VL - 117

SP - 299

EP - 308

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -